- Home
- CLVT vs AHCO Comparison
CLVT vs AHCO Comparison
Compare CLVT & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLVT | AHCO |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United Kingdom | United States |
| Employees | 12000 | N/A |
| Industry | EDP Services | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.6B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | CLVT | AHCO |
|---|---|---|
| Price | $2.82 | $11.35 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 4 |
| Target Price | $3.22 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 4.7M | 1.4M |
| Earning Date | 04-29-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,244,857,000.00 |
| Revenue This Year | N/A | $9.00 |
| Revenue Next Year | $2.12 | $6.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.66 | $8.33 |
| 52 Week High | $4.77 | $13.43 |
Technical Indicators
Market Signals| Indicator | CLVT | AHCO |
|---|---|---|
| Relative Strength Index (RSI) | 60.14 | 39.30 |
| Support Level | $2.29 | $8.79 |
| Resistance Level | $3.73 | $12.87 |
| Average True Range (ATR) | 0.19 | 0.53 |
| MACD | 0.02 | -0.26 |
| Stochastic Oscillator | 66.42 | 22.24 |
Price Performance
Historical ComparisonAbout CLVT Clarivate Plc
Clarivate is a data, information, and software workflow solutions company serving customers primarily in academia, government, law, life sciences, and healthcare. The company was formerly part of Thomson Reuters before being sold to private equity as an independent company in 2016. In 2019, Clarivate went public on the New York Stock Exchange. Around half of the company's revenue is generated in the Americas, while Europe, Middle East, and Africa account for around a quarter.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.